Innospec (IOSP) Research & Development (2016 - 2025)
Innospec (IOSP) has disclosed Research & Development for 16 consecutive years, with $11.0 million as the latest value for Q4 2025.
- Quarterly Research & Development fell 26.17% to $11.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $51.0 million through Dec 2025, down 9.73% year-over-year, with the annual reading at $51.0 million for FY2025, 9.73% down from the prior year.
- Research & Development hit $11.0 million in Q4 2025 for Innospec, down from $13.7 million in the prior quarter.
- In the past five years, Research & Development ranged from a high of $16.2 million in Q4 2023 to a low of $8.4 million in Q4 2022.
- Historically, Research & Development has averaged $11.6 million across 5 years, with a median of $10.8 million in 2023.
- Biggest five-year swings in Research & Development: skyrocketed 92.86% in 2023 and later fell 26.17% in 2025.
- Year by year, Research & Development stood at $9.5 million in 2021, then dropped by 11.58% to $8.4 million in 2022, then surged by 92.86% to $16.2 million in 2023, then fell by 8.02% to $14.9 million in 2024, then decreased by 26.17% to $11.0 million in 2025.
- Business Quant data shows Research & Development for IOSP at $11.0 million in Q4 2025, $13.7 million in Q3 2025, and $13.6 million in Q2 2025.